PH

Poorya Hosseini

Partner at Camford Capital

New York, New York

Overview 

Poorya Hosseini is the Founder & Investor at Camford Capital in New York, with a background in biotechnology and venture capital. Highlights of his career include founding multiple successful companies and holding a Ph.D. from MIT, showcasing his expertise in entrepreneurship and life sciences.

Work Experience 

  • Partner

    2021 - Current

    - Early-stage investments in life sciences and healthcare startups [focus on Seed / Series A] - Leading an initiative for incubation of pioneering ventures with next-gen entrepreneurs - Stealth RNA Therapeutics Platform (Founding CEO) - Carbon Biosciences (Board Observer)

Camford Capital is a venture capital firm that invests in Enterprise, Consumer, FinTech, and Healthcare companies.

  • Senior Associate

    2017 - 2021

    During my tenure, I worked as part of a team of entrepreneurial scientists to conceive, create, resource, and develop the next generation of Flagship’s ventures and helped train the next generation of scientists and venture builders.

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

  • Founding Team

    2019 - 2021

    Flagship Labs 72, Inc. (FL72) is an early-stage biotechnology company that is developing a new category of immune therapeutics (Stealth). I led the origination and launch of the company in addition to leading Operations and R&D during my tenure at Flagship.

  • Founding Team

    2018 - 2021

    Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of machine learning, biological engineering, and medicine—pioneering Generative Biology™ to create breakthrough medicines.

  • Founding Team

    2017 - 2021

    The company's broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.

Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.

Raised $294,000,000.00 from Kyowa Kirin, Flagship Pioneering and Hanwha Impact Partners.

  • Entrepreneurial Fellow

    2017 - 2017

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

  • PHD Candidate

    2012 - 2017

    I developed advanced imaging and microscopy techniques for biomedical applications. On the application side, I focused on anemic disorders and sickle cell disease in particular.

  • Graduate Research Assistant

    2008 - 2010

Articles About Poorya

Relevant Websites